NCT04632693

Brief Summary

Compare gingival thickness following CAF With SCTG and Vitamin C Versus SCTG Alone in Management of RT1 Gingival Recession.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 11, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 17, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2021

Completed
Last Updated

November 17, 2020

Status Verified

November 1, 2020

Enrollment Period

8 months

First QC Date

November 11, 2020

Last Update Submit

November 16, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Ginigval thickness

    Determined 2 mm apical to the gingival margin with a short needle for anesthesia and a 3 mm diameter silicon disk stop. The needle is inserted perpendicular to the mucosal surface, through the soft tissues with light pressure until a hard surface is felt. The silicon disk stop is then placed in tight contact with the soft tissue surface with the coronal border overlapping the soft tissue margin. As the needle is located in the center of the silicon disk, measurement of GT is performed 2 mm apical from the gingival margin. Once in the correct position, the disk is fixed with a drop of cyanocrylic adhesive; after careful removal of the needle, the penetration depth is measured with a caliper accurate to the nearest 0.1 mm.

    6 months

Secondary Outcomes (10)

  • Root Coverage Esthetic Score

    6 months

  • Early Healing Index

    6 months

  • Gingival Recession Depth (RD)

    6 months

  • Gingival Recession Width (RW)

    6 months

  • Percentage of root coverage

    6 months

  • +5 more secondary outcomes

Study Arms (2)

CAF with SCTG and vitamin C

EXPERIMENTAL

Coronally advanced flap with subepithelial connective tissue graft and vitamin C.

Procedure: CAF with SCTG and Vitamin C injection

CAF with SCTG

ACTIVE COMPARATOR

Coronally advanced flap with subepithelial connective tissue graft.

Procedure: CAF with SCTG alone

Interventions

Injection of vitamin C after CAF with SCTG aiming to increase gingival thickness in patients with RT1 gingival recession.

CAF with SCTG and vitamin C

Coronally advanced flap with subepithelial connective tissue graft.

CAF with SCTG

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients 18 years or older.
  • Periodontally and systemically healthy.
  • Buccal recession defects classified as Cairo RT1.
  • Presence of identifiable CEJ (Zucchelli et al., 2010).
  • Clinical indication and/or patient request for recession coverage.
  • O'Leary index less than 20% (O'Leary, Drake and Naylor, 1972).

You may not qualify if:

  • Cairo RT2 or RT3 recession defects.
  • Pregnant females.
  • Smokers as smoking is a contraindication for any periodontal plastic surgery (Khuller, 2009).
  • Handicapped and mentally retarded patients.
  • Patients undergoing radiotherapy.
  • Teeth with cervical restorations, abrasion and malalignment.
  • Presence of systemic disease that would affect wound healing.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Oral and Dental Medicine - CU

Cairo, Egypt

RECRUITING

MeSH Terms

Interventions

Ascorbic Acid

Intervention Hierarchy (Ancestors)

Sugar AcidsAcids, AcyclicCarboxylic AcidsOrganic ChemicalsHydroxy AcidsCarbohydrates

Central Study Contacts

Andrew Albert A. Zaki, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 11, 2020

First Posted

November 17, 2020

Study Start

September 1, 2020

Primary Completion

May 1, 2021

Study Completion

June 1, 2021

Last Updated

November 17, 2020

Record last verified: 2020-11

Locations